Cimeio Therapeutics Funding: $50M Raised, Series A (2022)
Cimeio Therapeutics is based in Basel, Switzerland. It has raised $50M in total funding. Latest round: Series A. Backed by Versant Ventures.
Cimeio Therapeutics funding overview
Cimeio Therapeutics is based in Basel, Switzerland. Cimeio Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2022. The round record for Cimeio Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Versant Ventures.
Cimeio Therapeutics at a glance
Total raised
$50M
Latest round
Series A
Latest round date
April 2022
Headquarters
Basel, Switzerland
Notable investors
Versant Ventures
Frequently asked about Cimeio Therapeutics funding
How much has Cimeio Therapeutics raised?
Cimeio Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Cimeio Therapeutics?
Versant Ventures are named among the investors backing Cimeio Therapeutics.
What was the latest Cimeio Therapeutics funding round?
The most recent disclosed round is a Series A, announced in April 2022.
Where is Cimeio Therapeutics based?
Cimeio Therapeutics is based in Basel, Switzerland.
When did Cimeio Therapeutics last raise?
The last disclosed Cimeio Therapeutics round closed in April 2022 at Series A.
Round data for Cimeio Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Basel and backer lists below.
